Foundation and Metabolon Collaborate to Unlock Biochemical Processes in CF
Aug. 1, 2008 | 1 min read

The CF Foundation is collaborating with Metabolon, Inc. to help bridge the gap between laboratory findings and the development of potential CF treatments. Metabolon will work with Cystic Fibrosis Foundation Therapeutics, the nonprofit affiliate of the Foundation, in a series of studies examining the chemical reactions that occur at the cellular level in CF.

Metabolon will analyze the basic mechanisms of CF to help discover markers and pathways associated with disease progression and drug action.

The Foundation hopes to gain further insight into the basic mechanisms of CF and uncover new opportunities for drug development.

Share this article
Topics
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Drug Pipeline
Recent news
Cystic Fibrosis Community Perspectives Influence Future of CF Care Model
News | 4 min read
CF Foundation Adapts Registry Reporting to New Race-Neutral Standards
News | 5 min read
Nearly 350 Advocates Urge Congressional Action During 17th Annual March on the Hill
News | 3 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe